David Mack
Fundador en PMV PHARMACEUTICALS, INC. .
Fortuna: 1 M $ al 30/04/2024
Cargos activos de David Mack
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PMV PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/06/2013 | - |
| Director Ejecutivo | 01/06/2013 | - | |
| Fundador | 01/06/2013 | - | |
| Presidente | 01/06/2013 | - | |
| ACMP IV LLC | Director/Miembro de la Junta | - | - |
Vitra Bioscience, Inc.
 Vitra Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Vitra Bioscience, Inc. develops technologies for biological research and drug discovery. Its technology includes cellcard system and cellplex assays which facilitate multiple cell-types and parameters to be evaluated. The cellcard imaging system collects images and then analyzed with proprietary software. The company was founded by Simon Goldbard and is headquartered in Mountain View, CA. | Director/Miembro de la Junta | - | - |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Director/Miembro de la Junta | 01/05/2006 | - |
Historial de carrera de David Mack
Antiguos cargos conocidos de David Mack.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Director/Miembro de la Junta | 19/02/2019 | 05/10/2020 |
| AERIE PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/06/2005 | 01/12/2013 |
| Independent Dir/Board Member | 19/09/2013 | 01/12/2013 | |
| SILENCE THERAPEUTICS PLC | Director/Miembro de la Junta | 08/01/2010 | 26/06/2013 |
Angiosyn, Inc.
 Angiosyn, Inc. Pharmaceuticals: OtherHealth Technology Angiosyn, Inc. develops pharmaceutical products for controlling angiogenesis | Director/Miembro de la Junta | 01/01/2003 | 01/01/2005 |
| Director Ejecutivo | 01/01/2003 | 01/01/2005 | |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Fundador | - | 02/01/2003 |
| Corporate Officer/Principal | - | 02/01/2003 | |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ | - |
Formación de David Mack.
| The University of Chicago | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 19 |
| Reino Unido | 2 |
Operativa
| Director/Board Member | 13 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
Sectorial
| Health Technology | 14 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| SUTRO BIOPHARMA, INC. | Health Technology |
| SILENCE THERAPEUTICS PLC | Commercial Services |
| PMV PHARMACEUTICALS, INC. | Commercial Services |
| Empresas privadas | 13 |
|---|---|
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Finance |
Vitra Bioscience, Inc.
Vitra Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Vitra Bioscience, Inc. develops technologies for biological research and drug discovery. Its technology includes cellcard system and cellplex assays which facilitate multiple cell-types and parameters to be evaluated. The cellcard imaging system collects images and then analyzed with proprietary software. The company was founded by Simon Goldbard and is headquartered in Mountain View, CA. | Health Technology |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Health Technology |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Proacta, Inc.
 Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Health Technology |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Pathwork Diagnostics, Inc.
 Pathwork Diagnostics, Inc. Medical SpecialtiesHealth Technology Pathwork Diagnostics Inc. develops and delivers molecular diagnostics for oncology. The company was founded by Glenda Anderson, Richard Zare, and George M. Whitesides in 2003 and is headquartered in Redwood City, CA. | Health Technology |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Health Technology |
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
| ACMP IV LLC | |
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
Angiosyn, Inc.
Angiosyn, Inc. Pharmaceuticals: OtherHealth Technology Angiosyn, Inc. develops pharmaceutical products for controlling angiogenesis | Health Technology |
| Cetus Corp. | Health Technology |
- Bolsa de valores
- Insiders
- David Mack
- Experiencia
